6 completed, 1 active not recruiting. 3 Not applicable, 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Active not recruiting 1 |
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Calo Psychiatric Center: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Acupuncture Treatment Effect in Patients With Schizophrenia Acupuncture - Mental Health | Not applicable | Active not recruiting | Calo Psychiatric Center | 100 | 2025-12-16 | 2026-01-22 |
| Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia cassia seed tablet - Schizophrenia | Phase 1 | Completed | Calo Psychiatric Center | 92 | 2018-05-17 | 2020-02-05 |
| Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega], Paliperidone Palmitate 546 MG Intramuscular Suspension, Extended Release [INVEGA TRINZA] - Schizophrenics | Phase 1 / Phase 2 | Completed | Calo Psychiatric Center | 72 | 2015-01-01 | 2021-02-15 |
| The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics Hawthorn, SGAs - Schizophrenia | Not applicable | Completed | Calo Psychiatric Center | 135 | 2013-01-01 | 2018-09-10 |
| Using Generalized Estimating Equation Analysis in a Study of Relaxation Training in Patients With Insomnia. relaxation training - Sleep Disorder; Insomnia Type | Not applicable | Completed | Calo Psychiatric Center | 24 | 2009-01-01 | 2024-12-12 |
| Predictive Validity of the Personal and Social Performance Scale for PANSS Outcomes in Schizophrenia This study employed a 12-week, multicenter, prospective research design focusing on the administration of the antipsychotic medication paliperidone. - Functional Outcomes | Phase 2 | Completed | Calo Psychiatric Center | 763 | 2008-03-10 | 2026-03-03 |
| Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics Olanzapine, risperidone, Paliperidone - Schizophrenia | Phase 1 | Completed | Calo Psychiatric Center | 111 | 2008-01-01 | 2019-02-15 |
Schizophrenia (4) · Dyslipidemias (1) · Obesity (1) · Psychological Well-Being (1) · Sleep Initiation and Maintenance Disorders (1) · Sleep Wake Disorders (1) · Social Adjustment (1)
Paliperidone Palmitate (2) · Acupuncture Therapy (1) · Olanzapine (1) · Relaxation Therapy (1) · Risperidone (1) · crataegus extract (1)
Taiwan (3)